Product Information

TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1056 per EA under NDC 53746061710. Its NADAC has been published 650 times since Mar 12, 2014.

FDA first approved this application on Dec 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB

Tramadol Hydrochloride and Acetaminophen
$0.1056per EA
DEA Schedule CIV

Strength

325; 37.5 mg/1; mg/1

NDC

53746061710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090485

FDA Approved

12/9/2009

TE Code

AB

On Market Since

12/17/2009

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has been published 650 times since Mar 12, 2014, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1056 per EA
All-time high$0.2270 (May 13, 2015)
All-time low$0.0806 (Nov 20, 2024)
52-week high$0.1145
52-week low$0.1014
Median price$0.1287
Average price$0.1449
Largest weekly change-29.5% (Jan 18, 2017)
Weeks tracked650
Tracking sinceMar 12, 2014

Price History

1W

+4.1%

1M

+4.1%

3M

+0.1%

6M

+2.3%

1Y

-6.1%

3Y

-8.5%

5Y

-12.6%

All

-52.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1056 per EA (NDC 53746061710), effective Aug 19, 2026.

How has the price of TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB changed over time?

Over the history we have for it, the NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has declined 52.1%. It has been tracked across 650 weekly CMS publications since Mar 12, 2014.

What are the highest and lowest recorded NADAC prices for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?

Since Mar 12, 2014, the NADAC for TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB has ranged from a low of $0.0806 (Nov 20, 2024) to a high of $0.2270 (May 13, 2015), with a median of $0.1287 per EA.

Are there cheaper alternatives to TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB?

TRAMADOL-ACETAMINOPHEN 37.5-325 MG TAB (NDC 53746061710) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.